by mparnell | Aug 29, 2018
KaNDy is developing NT-814 for the treatment of common, chronic debilitating female sex-hormone related conditions, with an initial focus on symptoms of the menopause. 
by mparnell | May 22, 2018
Sublimity Therapeutics is a biotechnology company developing therapies for the treatment of ulcerative colitis. 
by mparnell | May 14, 2018
Neurana is a biotechnology company developing tolperisone, a novel, patented skeletal muscle relaxant for the treatment of acute, painful muscle spasms without sedation. 
by mparnell | Apr 3, 2018
Axonics is a medical technology company developing a miniaturized rechargeable implantable neuromodulation technology to treat urinary and fecal dysfunction. 
by mparnell | Oct 19, 2017
Cydan is an orphan drug accelerator focused on identifying and de-risking programs with therapeutic and commercial potential.